These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15451829)

  • 41. [Clinical study of the month. Which initial antihypertensive? Results from the ALLHAT trial].
    Scheen AJ; Krzesinski JM
    Rev Med Liege; 2003 Jan; 58(1):47-52. PubMed ID: 12647599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 43. Strengthening diuretics' role in hypertension.
    Manag Care; 2010 Sep; 19(9):46. PubMed ID: 20931893
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
    Wang JG; Yan P; Jeffers BW
    J Am Soc Hypertens; 2014 May; 8(5):340-9. PubMed ID: 24685006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [VALUE].
    Okura T; Higaki J
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():419-24. PubMed ID: 16981573
    [No Abstract]   [Full Text] [Related]  

  • 46. Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Scott I; Stowasser M
    Intern Med J; 2003 Jul; 33(7):327-30. PubMed ID: 12823686
    [No Abstract]   [Full Text] [Related]  

  • 47. ALLHAT and ANBP2: what have we learned from recent mega-trials?
    Sander GE; Giles TD
    Am J Geriatr Cardiol; 2003; 12(4):267-71. PubMed ID: 12888711
    [No Abstract]   [Full Text] [Related]  

  • 48. Preventing vascular events due to elevated blood pressure.
    Yusuf S
    Circulation; 2006 May; 113(18):2166-8. PubMed ID: 16684871
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 50. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 51. [Results of clinical evidence: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)].
    Liakishev AA;
    Kardiologiia; 2003; 43(4):61-2. PubMed ID: 12968606
    [No Abstract]   [Full Text] [Related]  

  • 52. A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial.
    Mukhtar O; Cheriyan J; Cockcroft JR; Collier D; Coulson JM; Dasgupta I; Faconti L; Glover M; Heagerty AM; Khong TK; Lip GYH; Mander AP; Marchong MN; Martin U; McDonnell BJ; McEniery CM; Padmanabhan S; Saxena M; Sever PJ; Shiel JI; Wych J; Chowienczyk PJ; Wilkinson IB
    Am Heart J; 2018 Oct; 204():102-108. PubMed ID: 30092411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Not Available].
    Muheim L
    Praxis (Bern 1994); 2017; 106(5):271-272. PubMed ID: 28253804
    [No Abstract]   [Full Text] [Related]  

  • 54. ALLHAT in perspective: implications to clinical practice and clinical trials.
    Yusoff K
    Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antihypertensive therapy: campaign of the giants].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
    [No Abstract]   [Full Text] [Related]  

  • 56. Summaries for patients. Do the effects of blood pressure drugs differ by kidney function?
    Ann Intern Med; 2006 Feb; 144(3):I33. PubMed ID: 16461958
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial.
    Whittle J; Yamal JM; Williamson JD; Ford CE; Probstfield JL; Beard BL; Marginean H; Hamilton BP; Suhan PS; Davis BR;
    BMC Health Serv Res; 2016 Jul; 16():236. PubMed ID: 27391223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].
    González-Juanatey JR
    Rev Esp Cardiol; 2003 Jul; 56(7):642-8. PubMed ID: 12855144
    [No Abstract]   [Full Text] [Related]  

  • 59. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.